Authors


Alice Kerber, MN, APRN, ACNS-BC, AOCN, APNG

Latest:

"Oh, and by the way..." A Lynch Syndrome Story

Families are communities within themselves-full of intrigue, adventures, worries, joys, and assorted characters.


Bhavana Pothuri, MD

Latest:

Expert Weighs In On The Future of PARP Inhibitors

Advanced ovarian cancer is deadly for female patients with the disease, but results from a new study show promise for a new frontline treatment.


Dawn M. Carey RN, MSN, APN

Latest:

Dawn Carey, RN, on the Challenges of Treating Childhood Cancer Survivors

Dawn M. Carey RN, MSN, APN, LITE Program Coordinator, Pediatric Nurse Practitioner, Rutgers Cancer Institute of New Jersey, outlines some of the challenges when treating childhood cancer survivors as they age.


Shelagh Wright, PhD

Latest:

Shelagh Wright Discusses Components of Pain

Shelagh Wright, PhD, a retired lecturer from Dublin City University, discusses components of pain.



Kathleen Madden, RN, FNP-BC, AOCNP

Latest:

Kathleen Madden on the Importance of Patient Education

Kathleen Madden, from NYU Langone Medical Center, on the Importance Educating Patients About Ipilimumab's Side Effects.


Morganna Freeman, DO, FCAP

Latest:

Morganna Freeman on Helping Patients Focus on Treatment Not Stigma

Morganna Freeman, DO, FCAP, from The Angeles Clinic and Research Institute gives advice on how to help a patient who is dealing with the stigma associated with melanoma, or other cancers.


Tim Turnham

Latest:

Tim Turnham Discusses Programs Offered by the Melanoma Research Foundation

Tim Turnham, executive director, Melanoma Research Foundation, provides an overview of some of the services offered by the Melanoma Research Foundation.


Lance Ortega MBA, BSN, RN, OCN, Director, Nursing Services, Texas Oncology-Operational Excellence

Latest:

Alternative Recruitment Models for Oncology Nurses: An Outpatient RN Residency Program

Sadly, there is no magic fix for the problems in healthcare and nursing. To meet these different challenges, organizations must invest in programs that foster and mentor the next generation of nurses who are entering the profession.


Carol Bush, BS, RN

Latest:

Four LinkedIn Strategies You Can Employ for Nursing Career Success

Carol Bush explains a few key strategies to make LinkedIn work for your nursing career.


Hyman B. Muss, MD

Latest:

Hyman B. Muss Addresses Misconceptions About Pregnancy and Breast Cancer

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses misconceptions women have about being pregnant with a breast cancer diagnosis.


Anitra Cotton Hunt, Digital Coordinator, National Ovarian Cancer Coalition

Latest:

New Specialized Social Network Connects Women With Ovarian Cancer

The NOCC is connecting women who have ovarian cancer to others who are experiencing similar struggles.


Amy J. Hoffman, MSN, PhD, RN

Latest:

Switching Places: From Nurse to Caregiver

Coordination of care and educating patients and their caregivers needs to be the standard of care.


Jose Lutzky, MD

Latest:

Jose Lutzky on Proactively Monitoring Patients Receiving Immunotherapy Treatments

Jose Lutzky, MD, discusses the importance of proactive patient monitoring with patients receiving immunotherapy treatments.


Pamela Haylock, PhD, RN, FAAN

Latest:

Pamela Haylock on the Role of CSTDs

Pamela Haylock, PhD, RN, FAAN, past president, Oncology Nursing Society, discusses the role of closed-system drug-transfer devices (CSTDs).


Dawn L. Hershman, MD, MS

Latest:

Ovarian Suppression Plus AI Treatment Can Have Major Adverse Events

Combining ovarian suppression and an aromatase inhibitor is an efficacious treatment method for premenopausal women with breast cancer. However, the regimen (which is given long-term) can cause some major adverse events, explained Dawn L. Hershman, MD, MS, professor of medicine and epidemiology at the Columbia University Irving Medical Center.


Angela Moore, BS

Latest:

Answering Those "Million Dollar" Questions

Two nurse navigators report on the importance of equitable access to care, regardless of a patient's social connections, socioeconomic status, of philanthropy history.


Sunil Verma, MD, MSEd, FRCPC

Latest:

Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer

Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.


Jill Williams, RN, BSN, NP

Latest:

Reducing Central Line-Associated Bloodstream Infections

Decreasing hospital associated infection rates including Central Line–Associated Bloodstream Infections is an issue of ongoing focus nationwide.


Frahad Ravandi-Kashani, MD

Latest:

Measurable Residual Disease's Role in the Relapse Setting

MRD can prove useful in the treatment of patients with hairy cell leukemia who relapsed.


Charlotte Evans

Latest:

Helping Patients Tell Their Stories

"What's your opinion about using hair color?" I asked my doctor shortly before beginning chemotherapy. "I don't have an opinion," he said. "Talk to one of the nurses."


Tiki Barber

Latest:

Tiki Barber: Oncology Nurses Are "The Rock Patients Lean On"

Tiki Barber, former NFL running back and radio host, explains how he feels about oncology nurses, who helped his mother through her breast cancer experience.


Michael Soulen, MD

Latest:

Michael Soulen on Radioembolization of Neuroendocrine Tumor Liver Metastases

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.


Ellyn Matthews, PhD

Latest:

Ellyn Matthews on Addressing Sleep Disturbances

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, discusses the role of oncology nurses in handling sleep disturbances.


Courtney Marabella

Latest:

Patients With HER2+ Breast Cancer and Brain Metastases Achieve Better OS With Tucatinib Triplet Regimen

A triplet regimen of tucatinib, trastuzumab, and capecitabine helped patients with HER2-positive metastatic breast cancer and brain metastases live longer with reduced disease progression compared with trastuzumab and capecitabine alone.


Brielle Urciuoli

Latest:

Ketamine May Benefit Those With Difficult Pain From Ovarian Cancer

Ketamine, typically used to kickstart and maintain anesthesia use, could be an option for treating patients with ovarian cancer whose pain is difficult to treat.


Laura Rutledge, MA, RDN, CSO

Latest:

Grilling and Cancer: Turn Down the Summer Heat

What you grill—and how you grill—can potentially produce cancer-causing substances. Here are 3 tips nurses can share with others to reduce the risk of carcinogen formation and still enjoy grilled food.


Sagar Lonial, MD

Latest:

Sagar Lonial Discusses Treating Patients With Myeloma

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.


Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center

Latest:

Assessing Barriers to Oral Oncolytic Adherence

Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center in Covington, Louisiana, shares some barriers to adherence to oral oncolytics that patients may face.


OLIVER DORIGO, M.D., PH.D.

Latest:

Future Focus: Ovarian Cancer in 2018 and Beyond

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses the work ahead in the ovarian cancer field.